Invariant natural killer T cells (iNKT cells) have an innate immunity-like rapidity of response and the ability to modulate the effector functions of other cells. We show here that iNKT cells specifically expressed the BTB-zinc finger transcriptional regulator PLZF. In the absence of PLZF, iNKT cells developed, but they lacked many features of innate T cells. PLZF-deficient iNKT cells accumulated in lymph nodes rather than in the liver, did not express NK markers and did not have the characteristic activated phenotype. PLZF-deficient iNKT cells failed to secrete large amounts of interleukin 4 and interferon-c after activation; however, some cells produced either interleukin 4 or interferon-c but not both. PLZF, therefore, is an iNKT cell-specific transcription factor that is necessary for full functionality.
Invariant natural killer T cells (iNKT cells) have an innate immunity-like rapidity of response and the ability to modulate the effector functions of other cells. We show here that iNKT cells specifically expressed the BTB-zinc finger transcriptional regulator PLZF. In the absence of PLZF, iNKT cells developed, but they lacked many features of innate T cells. PLZF-deficient iNKT cells accumulated in lymph nodes rather than in the liver, did not express NK markers and did not have the characteristic activated phenotype. PLZF-deficient iNKT cells failed to secrete large amounts of interleukin 4 and interferon-c after activation; however, some cells produced either interleukin 4 or interferon-c but not both. PLZF, therefore, is an iNKT cell-specific transcription factor that is necessary for full functionality.
Most hematopoietic cells mature in the bone marrow. In contrast, multipotent progenitor T cells leave the bone marrow and migrate to the thymus, where signals from stromal cells are required for commitment to the T lineage 1 . Once directed into the T lineage, the cells undergo a rigorous selection process that eliminates more than 95% of the candidate T cells. Full maturation requires the expression of a T cell receptor (TCR) that binds self peptide presented by self major histocompatibility complex (MHC) molecules with sufficient avidity. At some point during development, T cells are directed into one of several distinct T cell lineages such as CD4 + single-positive 'helper' cells, CD8 + single-positive 'killer' cells or CD4 + CD25 + regulatory cells. Commitment to these various lineages defines the specialized functions of the cell; this is critical, as each cell type has an essential and distinct function for host defense. The genes responsible for directing multipotent T cell progenitors into the various lineages are mostly unknown 2 .
Among the various lineages of T cells, invariant natural killer T cells (iNKT cells) have several unique phenotypic traits, such as the expression of receptors typically associated with NK cells, the constitutive expression of activation markers and extremely restricted TCR diversity 3 . The iNKT cells express an identical TCRa chain and most use a TCRb chain that uses the variable b-region 8.2 (V b 8.2) gene segment. This TCR confers specificity to the non-MHC-encoded self molecule CD1d, which binds and presents glycolipids rather than the typical peptide cargo presented by conventional MHC molecules.
The iNKT cells are also functionally distinct. Of particular note is their ability to secrete large quantities of a variety of cytokines only minutes after activation through the TCR 3 . The rapid response of these cells, the conserved nature of the TCR and the indirect ability of these cells to modulate the function of many different cell types of the immune system has led to the appreciation that iNKT cells are at a functional 'cusp' between the innate and adaptive immune systems 4 . The broad range of cytokines released by iNKT cells results in their potential to regulate seemingly opposing immune responses. For example, iNKT cells have been shown to enhance immune responses to tumors, but they have also been shown to prevent autoimmunity by diminishing self-reactive T cell responses 5 .
The expression of a TCR specific for the CD1d ligand loaded with an appropriate glycolipid is the only unique identifier of iNKT cells. This highly conserved TCR also allows for the direct detection of iNKT cells by the use of a 'tetramerized' version of the CD1d molecule loaded with a glycolipid called 'a-galactosylceramide' (a-GalCer) 6 . This reagent allows for the unambiguous detection of iNKT cells, which has made these cells much more amenable to genetic studies than are the extremely diverse conventional T cell populations. As a result, several genes that influence iNKT cell development have been identified. For example, the failure to express any one of several proteins, such as the transcription factor T-bet or colony-stimulating factor 2 (CSF-2), affects events late in development and typically results in altered iNKT cell function 7 . Loss of expression of the Src family kinase Fyn severely affects development, presumably because of less signaling through the TCR or other receptors, such as SLAM (signaling lymphocytic activation molecule) [8] [9] [10] . Interactions between SLAM family members seem to control diverse immunoregulatory functions during a variety of cellular interactions 11 . The requirement for SLAM interactions for iNKT cell development is clear, as mice and humans that do not express the SLAM family adaptor protein SAP do not have iNKT cells [12] [13] [14] . The Runx1 transcription factor has also been shown to be required for iNKT cell development 15 . Loss of Runx1 expression, however, has severe and pleiotropic affects on thymocyte development. Indeed, none of the gene products that have been identified to affect iNKT cell development are uniquely expressed in iNKT cells.
The BTB-POZ-ZF (broad complex, tramtrack, bric-à-brac (BTB) or poxvirus and zinc finger (POZ)-zinc finger) family of transcription factors controls a wide variety of biological processes 16 . These BTBzinc finger (BTB-ZF) family members are defined by the presence of an amino-terminal protein-protein interaction domain (BTB-POZ) and carboxy-terminal C 2 H 2 zinc-finger domains. Several proteins in this family have transcriptional repressor activity. BTB-ZF proteins have also been shown to control several fundamental aspects of immune system function. For example, Bcl-6 controls the germinal center reaction that is required for the affinity maturation of B cells 17 . In T cells, it has been shown that Th-POK is the 'master regulator' of the CD4-versus-CD8 lineage-commitment step in the thymus 18, 19 , which is fundamental for T cell function. And the T cell-versus-B cell fate 'decision' has also been shown to be controlled by LRF 20 . Here we report that the promyelocytic leukemia zinc finger protein PLZF (also called ZBTB16), another member of the BTB-ZF family, is necessary for the development of iNKT cells.
RESULTS

Restriction of PLZF expression to iNKT cells
Recognizing the increasing number of BTB-ZF finger proteins involved in the function of the immune system, we screened various thymocyte populations for the expression of several different family members. Many of the genes encoding BTB-ZF family members that we analyzed were expressed in all thymic subpopulations (data not shown). One, however, Zbtb16, which encodes the transcription factor PLZF 21 , had higher expression in iNKT cells than in conventional T cells. The expression of PLZF in iNKT cells was apparent in thymocytes and also in lymphocytes isolated from mouse livers (Fig. 1a) . To further analyze PLZF expression patterns, we used a new monoclonal antibody directed against the hinge region of the protein. We determined the specificity of this antibody to PLZF (anti-PLZF) both by fluorescenceactivated cell sorting of T cells from PLZF-deficient mice 22 (discussed below) and by immunoblot of cells overexpressing PLZF (Fig. 1b and Supplementary Fig. 1 online) . We used a-GalCer-CD1d tetramers 6 to specifically identify iNKT cells (Fig. 1b, left) . Intracellular staining for PLZF in iNKT cells and conventional T cells showed that this transcription factor was expressed in variable amounts in thymic iNKT cells and was moderately expressed in liver iNKT cells (Fig. 1b, right) . However, we did not find PLZF in conventional thymocytes or conventional liver T cells (Fig. 1b) .
We collected peripheral blood lymphocytes from humans and examined their expression of PLZF by flow cytometry. We identified iNKT cells with the 6B11 monoclonal antibody 23 , which recognizes a unique determinant in the TCR V a 24 complementarity-determining region 3, in combination with an anti-CD3 (Fig. 1c) . We detected PLZF by intracellular staining with our antibody to mouse, which cross-reacted with the human protein. Human iNKT cells expressed PLZF, whereas CD3 + T cells expressed little or no PLZF (Fig. 1c) . The development of iNKT cells is typically categorized into three stages 24 , identified mainly by the cell surface upregulation of CD44, followed by NK1.1 (Fig. 1d) . Nearly all cells at stage 1 (tetramerpositive CD44 lo NK1.1 -) had abundant expression of PLZF. The extremely rare PLZF -events (about 0.012%) among these cells could not be definitively determined to be 'real' iNKT cell events, as staining with empty tetramer resulted in the detection of similar events ( Supplementary Fig. 2 online) . Consistent with the finding that PLZF is downregulated in other cell types during differentiation, including CD34 + human stem cells 25, 26 , we found that PLZF was downregulated in iNKT cells in the more mature populations at stages 2 and 3 (Fig. 1d) . PLZF expression at stage 3 was equivalent to that in mature iNKT cells of the liver.
T-bet-deficient iNKT cells are blocked at stage 2 of development 27 (Fig. 1e) . The expression of PLZF in these genetically blocked iNKT cells was similar to that of wild-type cells at stage 1 of development. Stage-2 cells from the T-bet-deficient mice only partially downregulated PLZF (Fig. 1e) . These data suggest that regulation of PLZF expression is tightly linked to the stage of iNKT cell development.
Young mice have many more immature, developing iNKT cells than do adult mice 9 . Therefore, we examined 10-to 13-day-old mice to determine the expression of PLZF in early subsets of cells typically not detectable in adult mice. CD44 -CD24 hi iNKT cells, which are thought to represent the most immature iNKT cell population in the thymus, had abundant expression of PLZF (Fig. 1f) . As the developing iNKT cells began to express CD44 (stage 1; CD44 lo ), CD24 was downregulated, whereas PLZF expression remained high (Fig. 1f) . As seen in adult mice (Fig. 1d) , PLZF expression continued to decrease with the maturation state of the cells.
Normal lymphocyte development in the absence of PLZF To further examine the expression of PLZF in the lymphoid compartment, we examined B cells and NK cells by flow cytometry. We did not detect PLZF in either of these cell types (Fig. 2a) . We also did not detect PLZF in eosinophils, neutrophils or macrophages (data not shown).
PLZF-deficient mice have disrupted patterning of the hind limbs 22 and a progressive loss of spermatogonia 28 . The development of the hematopoietic system, however, was not overtly perturbed in PLZFdeficient mice (Fig. 2b) . For example, we found similar percentages of all thymic subpopulations in the mutant and wild-type mice. The cell numbers of each population were proportionally lower, however, as thymi of PLZF-deficient mice were consistently about 25% smaller. This smaller size did not alter the thymic structure, however (Fig. 2c) . Furthermore, thymocytes expressing an MHC class II-restricted TCR transgene developed normally in the absence of PLZF (data not shown). PLZF-deficient mice had wild-type percentages and numbers of lymph node and spleen T cells ( Fig. 2b and data not shown). DX5 + T cells, which represent mainly non-CD1d-restricted NKT cells 29 , NK cells and gd T cells were also present in wild-type numbers (Fig. 2d) . Finally, we found no obvious differences in the B cell compartment (data not shown). Therefore, consistent with the restricted expression pattern of PLZF, the bulk of the lymphoid compartment was intact. The alteration in thymic cellularity seemed to be secondary to any affects that PLZF may have had on T cell development.
Altered iNKT cell development in PLZF-deficient mice
Although conventional T cell development was not perturbed in the absence of PLZF, the frequency of CD1d tetramer-positive iNKT cells in the PLZF-deficient thymus was about 10% as much as that of wildtype thymus (Fig. 3a) . We demonstrated the specificity of the flow cytometry staining of iNKT cells by comparing it with that of CD1d-deficient mice 30 (Fig. 3a) , which are devoid of iNKT cells because they lack the selecting ligand, and by staining with 'empty' CD1d tetramer (data not shown). The detection of some tetramer-positive cells was important for several reasons. First, tetramer binding proved that the invariant TCRa chain can be generated by variable-diversity-joining recombination. This is different from the situation in RORgt deficient mice, in which the V a 14-to-J a 18 (variable-to-joining) recombination that generates the canonical TCRa chain does not occur 15 . We also confirmed generation of the iNKT TCRa chain by PCR of cDNA, followed by DNA sequencing (data not shown). Second, the iNKT cells in the PLZF-deficient mice must have undergone positive selection. Random variable-diversity-joining recombination of the Tcrb and Tcra loci is estimated to produce at least 1 Â 10 15 different TCR combinations 31 . Therefore, the frequency of 1 tetramer-positive cell per approximately 2,500 thymocytes (about 0.04%) that we found in the PLZF-deficient mice (Fig. 3a) must have been a consequence of positive selection that resulted in the enrichment of thymocytes expressing this TCR. Third, the presence of tetramer-positive cells suggested that we could directly examine the phenotype and function of iNKT cells in the absence of PLZF. CD44, an activation marker for conventional T cells, is upregulated during development of all iNKT cells in the thymus and is constitutively expressed by all mature iNKT cells. The tetramer-positive iNKT cells in the thymi of PLZF-deficient mice, however, had not upregulated CD44 (Fig. 3b) . Nearly half of the PLZF-deficient iNKT cells had upregulated CD69, which, like CD44, is a marker of T cell activation that is expressed by most mature iNKT cells. In the thymus, CD69 also serves as a marker for thymocytes that have productively interacted with self MHC molecules and, therefore, upregulation of CD69 suggested that the PLZF-deficient iNKT cells had signaled through the TCR. The requirement for PLZF was intrinsic to iNKT cells, as the transfer of PLZF-deficient bone marrow into irradiated C57BL/6 host mice resulted in the development of few CD44 lo iNKT cells (Supplementary Fig. 3 online) . The transfer of bone marrow from wild-type littermates into C57BL/6 hosts resulted in the expected frequencies of iNKT cells that fully matured to the CD44 hi CD69 + stage. Additionally, flow cytometry showed that CD1d expression was not altered in PLZF-deficient mice ( Supplementary Fig. 4 online) .
The iNKT cells are known to proliferate during the early stages (CD24 lo CD44 lo ) of thymic development. This expansion seems to be subsequent to positive selection 32 . We assessed the division of iNKT cells in wild-type and PLZF-deficient mice by analyzing incorporation of the thymidine analog bromodeoxyuridine (BrdU) into iNKT cells. We injected young mice with BrdU and killed them 16 h later. We stained iNKT cells with anti-CD44, anti-CD69, CD1d tetramer and anti-CD3, then made them permeable and stained them with antiBrdU. We tested the incorporation of BrdU into CD4 -CD8 -thymocytes as a positive control (data not shown). The percentage of BrdU + iNKT cells in the absence of PLZF was similar to that of wild-type cells (Fig. 3c) . We obtained similar results when we compared total iNKT cells or only CD44 lo cells.
Wild-type iNKT cells transit through the CD4 + CD8 + doublepositive stage in the thymus 9, 15, 33 , then downregulate CD8 to become CD4 + single-positive cells. Of these, nearly half also downregulate CD4 (ref.
3). The iNKT cell population, therefore, always consists of high percentages of both CD4 + and CD4 -cells (Fig. 3d) . In humans, CD4 + and CD4 -iNKT cells have been shown to be functionally distinct 34 . Notably, in PLZF-deficient mice, this ratio was skewed toward CD4 + iNKT cells (Fig. 3d) . PLZF-deficient iNKT cells had lower expression of NK1.1, DX5, NKG2D, 2B4 (CD244) and CD122, markers typically expressed by iNKT cells 35 , (Fig. 3e) . Finally, nearly all the PLZF-deficient iNKT cells in the thymus downregulated CD24 (Fig. 3e) . The finding of fewer iNKT cells in the thymus of PLZF-deficient mice was not due to more apoptosis, as these cells were negative for annexin V staining ( Supplementary Fig. 5 online) . Moreover, iNKT cells left the thymus and could be detected in the livers of PLZFdeficient mice (Fig. 4a) . As in the thymus, the frequency of iNKT cells in the liver was much lower (on average, about 2.3% that of wild-type; Fig. 4a ). Also as in the thymus, PLZF-deficient liver iNKT cells were mostly CD44 lo (Fig. 4b) and were skewed toward being CD4 + (Fig. 4c) .
Although iNKT cell development is severely impaired in the absence of the kinase Fyn, some iNKT cells do accumulate in the livers of older mice. We analyzed these cells to determine if PLZF expression was dependent on Fyn-mediated signaling events. SLAM family receptor signaling, which is mediated by the adaptor protein SAP and is dependent on Fyn, is required for the development of iNKT cells. PLZF expression in Fyn-deficient iNKT cells was essentially identical to that in wild-type iNKT cells (Fig. 4d) , which suggested that SLAM family-mediated signals were not required for PLZF expression.
PLZF-deficient iNKT cells in lymph nodes and spleen
In contrast to the many fewer PLZF-deficient iNKT cells in the thymus and liver, PLZF-deficient mice actually had approximately twofold more iNKT cells in the lymph nodes than did wild-type mice (Fig. 5a) . We also found iNKT cells among the spleen cells of PLZF-deficient mice (Fig. 5a) , although the frequency was lower than that of iNKT cells in wild-type spleens (Fig. 5a) . PLZF-deficient iNKT cells in the lymph nodes and spleen were CD44 lo and were mostly CD69 - (Fig. 5b) . PLZF-deficient iNKT cell populations in the lymph nodes also had a much higher ratio of CD4 + cells to CD4 -cells than did wild-type iNKT populations (Fig. 5c) . Similar to PLZF-deficient thymic iNKT cells, iNKT cells in PLZFdeficient spleens and lymph nodes had much lower expression of NK1.1, DX5, NKG2D, 2B4 and CD122 (Fig. 5d and data not shown) . The relative number of NK1.1 + NKT cells versus NK1.1 -NKT cells varied in the lymph nodes and spleens of wild-type mice but was in agreement with published reports 6 . Furthermore, resting PLZF-deficient iNKT cells expressed much less granzyme B (Supplementary Fig. 6 online) . We also assessed FasL ( Supplementary Fig. 6 ) and perforin (data not shown) but did not detect them on either wild-type or PLZF-deficient iNKT cells. Finally, we assessed interleukin 4 (IL-4) expression by RT-PCR of cDNA made from sorted wild-type and PLZF-deficient iNKT cells ( Supplementary Fig. 7 online) . We did not detect 'preformed' IL-4 message, a characteristic of iNKT cells 36 , in PLZFdeficient iNKT cells.
Functional analysis of PLZF-deficient iNKT cells
Shortly after activation, iNKT cells secrete copious amounts of various cytokines, including IL-4 and interferon-g (IFN-g) 3 . To test if PLZF-deficient iNKT cells had these critical effector functions, we immunized wild-type and PLZF-deficient mice with the iNKT cell antigen a-GalCer. Cytokine secretion by the iNKT cells then leads to activation of many other cells of the immune system 3 . Within 6 h of iNKT cell activation with a-GalCer, B cells, T cells, NK cells and macrophages all upregulated the activation marker CD69 in wild-type mice (Fig. 6a) . No measurable activation of these cell types, however, occurred after immunization of PLZF-deficient mice with a-GalCer, similar to results obtained with the negative control, CD1d-deficient mice. IL-2, IL-4 and IFN-g were readily detectable in the serum of wild-type mice after a-GalCer immunization; however, these cytokines could not be detected in PLZF-deficient mice or the CD1d-deficient control mice (Fig. 6b) .
The failure to detect cytokines in immunized PLZF-deficient mice might have been due to the lower frequency of iNKT cells. Therefore, to further test iNKT cell function, we sorted tetramer-positive iNKT cells from the spleens and lymph nodes of wild-type and PLZFdeficient mice. We activated sorted cells with phorbol 12-myristate 13-acetate and ionomycin for a total of 5 h and added brefeldin A for the final 4 h of the culture. We then analyzed cytokine production by the activated cells by intracellular staining, followed by flow cytometry. As expected, a large percentage of wild-type iNKT cells produced cytokine in these conditions, with approximately half of the activated cells expressing both IL-4 and IFN-g (Fig. 7a) . Notably, far fewer PLZF-deficient iNKT cells expressed the cytokines (Fig. 7a) . Of particular note was the complete loss of the ability to simultaneously produce both IL-4 and IFN-g. CD4 + T cells from wild-type and PLZFdeficient mice produced some IFN-g and little IL-4 (Fig. 7a) .
To further analyze the functionality of PLZF-deficient iNKT cells, we activated sorted cells with plate-bound anti-CD3 and soluble anti-CD28, allowed them to 'rest' for 5 d in fresh medium and then reactivated them in fresh medium. As a control and for comparison, we also collected wild-type and PLZF-deficient CD4 + T cells and grew them in the same culture conditions. We analyzed a variety of cytokines in the supernatants of the primary and secondary activations. As suggested by the experiments reported above (Figs. 6 and  7a) , PLZF-deficient iNKT cells produced little IL-4 and IFN-g after primary activation (Fig. 7b) . The failure to produce cytokines was not a general defect of the cells, however, as after secondary activation, PLZF-deficient iNKT cells had robust production of these two cytokines (Fig. 7b) . The limited capacity of PLZF-deficient iNKT cells to produce IL-4 and IFN-g after primary activation was in contrast to results obtained with wild-type iNKT cells (Fig. 7c,d ). Wild-type iNKT cells also produced more IL-4 and IFN-g after secondary activation than did PLZF-deficient iNKT cells (Fig. 7c,d ). CD4 + T cells were not affected by the loss of PLZF (Fig. 7c,d ). Like 1 0 6 0 VOLUME 9 NUMBER 9 SEPTEMBER 2008 NATURE IMMUNOLOGY PLZF-deficient iNKT cells, the CD4 + T cells had little secretion of cytokines after primary activation and much more IL-4 and IFN-g after secondary activation (Fig. 7c,d ).
After primary activation, iNKT cells are known to produce many cytokines, including IL-3, IL-5, IL-9, IL-10, IL-12p70, IL-13, granulocyte-monocyte colony-stimulating factor (GM-CSF) and tumor necrosis factor (TNF) 5 . Therefore, we further tested supernatants for the presence of these cytokines (Fig. 8) . Wild-type iNKT cells produced significantly more IL-13, GM-CSF, IL-10 and IL-3 and TNF than did PLZF-deficient iNKT cells after primary activation. We did not detect IL-5, IL-9 or IL-12p70 in these activating conditions. Secondary activation of the cells showed that PLZF-deficient iNKT cells were able to produce all these cytokines (Fig. 8) . Wildtype iNKT cells produced significantly more IL-13 and IL-10 after secondary activation; they also produced more TNF than PLZF-deficient iNKT cells did, but this difference did not reach statistical significance. PLZF-deficient CD4 + T cells acted like wildtype CD4 + T cells, with little production of cytokines after primary activation and much more after secondary activation. Therefore, in the absence of PLZF, iNKT cells do acquire innate effector functions. Furthermore, the loss of PLZF does not affect the function of CD4 T cells in any measurable way.
DISCUSSION
We have shown here that in the absence of PLZF, iNKT cells developed, but they failed to acquire many of the salient features characteristic of these cells. In particular, the frequency of PLZFdeficient iNKT cells was lower, the cells did not have high expression of cell surface markers such as NK1.1, DX5, 2B4, CD122 and NKG2D, and the cells failed to produce many cytokines after primary activation. PLZF-deficient cells also expressed less granzyme B and did not have the preformed IL-4 mRNA characteristic of wild-type iNKT cells. Furthermore, PLZF-deficient iNKT cells accumulated in the lymph nodes and spleen rather than in the thymus and liver, similar to Figure 8 Loss of PLZF expression affects the expression of many cytokines. Cytokine bead array analysis of TNF, IL-13, GM-CSF, IL-3 and IL-10 in supernatants generated and collected as described in Figure 7b ; IL-5, IL-9 and IL-12p70 were not detected in these conditions. *, P o 0.05; **, P o 0.005, PLZF-deficient iNKT cells versus wild-type iNKT cells, PLZF-deficient CD4 + cells and wild-type CD4 + cells (two-tailed, unpaired Mann-Whitney U-test). Data are representative of five independent experiments (mean and s.d. of triplicates, averaged and considered a single data point).
NATURE IMMUNOLOGY VOLUME 9 NUMBER 9 SEPTEMBER 2008 1 0 6 1 wild-type CD4 + cells. Finally, among cells of the immune system, PLZF expression seemed to be limited mainly to iNKT cells. These data collectively show that PLZF is a critical regulator of iNKT cell differentiation. PLZF was also expressed in human iNKT cells, in which this highly conserved protein probably has a similar function. The failure of iNKT cells to acquire innate T cell effector functions in the absence of PLZF was possibly due to a blockade in development. Indeed, the PLZF-deficient iNKT cells resembled an early stage of development identified before 37 . This stage of development is described as CD4 + or CD4 -, CD44 lo and NK1.1 -, somewhat similar to the PLZF-deficient iNKT cells, which were mostly CD4 + CD44 -NK1.1 -. However, a key identifying feature of the previously described immature iNKT cell population is that they produce copious IL-4 but no IFN-g after primary activation 37 . That is distinct from PLZFdeficient iNKT cells, which expressed little IL-4 and some IFN-g. An alternative possibility is that the function of PLZF is akin to the function of Th-POK in CD4-versus-CD8 lineage commitment 18 . If so, then in the absence of PLZF, iNKT cells simply develop into a naive CD4 + T cell-like lineage.
PLZF is probably not involved in the positive selection of iNKT cells, as PLZF-deficient mice did develop many T cells expressing canonical TCRs. However, PLZF was highly expressed even in CD24 hi CD44 -iNKT cells, which are the most immature cells that have been described 32 . Therefore, PLZF expression must occur immediately after or perhaps even during positive selection of iNKT cells.
It is not clear why the thymi, livers and spleens of PLZF-deficient mice had fewer iNKT cells. The lower frequency of iNKT cells was not a direct consequence of altered proliferative capacity in the thymus, as a similar percentage of PLZF-deficient and wild-type iNKT cells were labeled with BrdU over a 16-hour period. TCRb + thymocytes at the double-negative stage of development have been shown to undergo a population expansion of about 500-fold within 4 d (ref. 38) . Each TCRb clone divides more than three times a day, on average. It is speculated, however, that different clones may expand with different kinetics. Therefore, it is possible that wild-type iNKT cells, like some double-negative thymocytes, were undergoing more rounds of division than were PLZF-deficient iNKT cells. It is not possible to reach conclusions about the total number of cell divisions, as BrdU labeling does not differentiate between cells that have undergone one round or several rounds of proliferation.
There was no indication that PLZF-deficient iNKT cells were dying. The cells in the thymus were not annexin V positive and could migrate from the thymus and populate peripheral tissues. Apoptotic thymocytes are rapidly cleared from the thymus, however, so more cell death remains a formal possibility. It is also possible that PLZF-deficient iNKT cells simply do not accumulate in the thymus and liver because they fail to express chemokine receptors necessary for their retention in these tissues. Furthermore, it is known that NK1.1 -iNKT cells emigrate more readily from the thymus than do NK1.1 + iNKT cells 39 . As PLZF-deficient iNKT cells did not upregulate NK1.1, it is possible that these cells more efficiently leave the thymus.
It is not known how PLZF expression is restricted to iNKT cells. Engagement of SLAM family receptor signals through Fyn may result in PLZF expression, as the SLAM adaptor protein SAP is required for iNKT cell development 14, 40 . Furthermore, the SLAM family receptors Slamf1 and Slamf6 have been shown to be critical for iNKT cell development 41 . SAP is thought to signal through Fyn and, in the absence of Fyn, there is much lower frequency of iNKT cells 8, 10 . However, wild-type and Fyn-deficient iNKT cells have similar expression of PLZF. Preliminary data also show that the rare CD1d tetramer-positive cells found in the thymi of SAP-deficient mice express PLZF (data not shown). These data would suggest that SLAM-mediated signaling is not essential for PLZF expression. Alternatively, the few iNKT cells that develop in these SAP-and Fyn-deficient mice might be 'escapees' that have managed to express PLZF without appropriate signaling events.
Several gene products have been shown to affect the development and/or function of iNKT cells. For example, T-bet-deficient mice have a profound block at stage 2 of iNKT cell development 27 . RORgtdeficient mice are devoid of iNKT cells as a result of a failure to produce the invariant V a 14 TCR because of the short lifespan of CD4 + CD8 + thymocytes 15 . That same report has shown that Runx1 is necessary for the very early stages of iNKT cell development. GM-CSF (CSF-2) has also been shown to be important for iNKT cells. The iNKT cells of GM-CSF-deficient mice develop normally, but they fail to secrete cytokines because of a defect in secretory vesicles 42 . It has been shown that mice deficient in the Tec family tyrosine kinase ITK have defects in iNKT cell development 43, 44 . The defects in iNKT cell function and phenotype, although seemingly related, are far milder than the changes in PLZF-deficient iNKT cells. The CD4 + and CD8 + T cells of ITK-deficient mice have also been shown to have innate-like features [45] [46] [47] [48] [49] . However, the innate-like T cells in ITK-deficient mice do not seem to express PLZF (data not shown).
BTB-ZF proteins have typically been found to be transcriptional repressors. For example, Bcl-6 represses expression of the tumor suppressor p53 in germinal center B cells, presumably to prevent the apoptotic cell death that the double-stranded DNA breaks associated with affinity maturation should cause 50 . Another example is LRF, which is thought to suppress Notch-mediated signals in hematopoietic stem cells, thereby promoting B cell commitment over T cell commitment 20 . Targets of PLZF include the gene encoding HoxD, which is involved in skeletal morphogenesis during limb bud formation 51 , and the gene encoding the stem cell factor receptor c-Kit during spermatogonial differentiation 52 . Neither of these gene products, however, has been reported to have a function in iNKT cells. Cell line-based studies also suggest that genes encoding the transcription factor Pbx1 (which controls several embryonic processes) 53 , the integrin VLA-4 (ref. 54) , the proto-oncogene product c-Myc 55 and the proapoptotic BH3-only gene product BID 56 are transcriptionally repressed by expression of PLZF. Preliminary gene array data show that expression of the genes encoding these molecules is not altered in PLZF-deficient iNKT cells. Expression of Th-POK 18 , encoded by another gene of the BTB-ZF family known to be expressed in iNKT cells, was also not affected by the loss of PLZF expression (data not shown). Perhaps PLZF suppresses unknown suppressors of transcription factors required for cytokine production such as T-bet 57 or RORgt 58 . Indeed, both T-bet and RORgt have been shown to be essential for iNKT cell development 15, 27 .
Finally, it is notable that PLZF-deficient iNKT cells did not have an activated phenotype. It has been generally accepted that iNKT cells are not tolerant to self and that this is probably the reason the cells maintain an activated phenotype 7, 59 . Reactivity to self has been proposed to be a consequence of the unique and highly restricted TCRs that are expressed by iNKT cells. The failure of PLZF-deficient iNKT cells to maintain an activated phenotype indicates that high-affinity interactions of the TCR with self antigens are not involved in maintaining the activated phenotype of iNKT cells. Instead, it would seem that expression of PLZF controls this aspect of iNKT cell biology. Overall, our findings offer fundamental insight into the mechanisms of iNKT cell development. Our work also emphasizes the fundamental role of BTB-ZF proteins in immune system development and function.
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